# PIPAC in Gastric Peritoneal Metastasis

> **NCT07517419** · PHASE2 · ENROLLING_BY_INVITATION · sponsor: **Chinese University of Hong Kong** · enrollment: 30 (estimated)

## Conditions studied

- Gastric Cancer Peritoneal Metastases

## Interventions

- **DRUG:** Cisplatin and Doxorubicin

## Key facts

- **NCT ID:** NCT07517419
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2021-10-11
- **Primary completion:** 2031-02-28
- **Final completion:** 2031-02-28
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07517419

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07517419, "PIPAC in Gastric Peritoneal Metastasis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07517419. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*